SMTL ID : 1d1y.1

BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1,3-PBITU (H4B FREE)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

homo-dimer

Ligands

4 x ACT: ACETATE ION(Non-functional Binders)

ACT.1: 4 residues within 4Å: Chain A: Q.211, R.214, N.330, R.336 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:Q.211, A:N.330 Salt bridges: A:R.214, A:R.336 ACT.2: 4 residues within 4Å: Chain A: G.150, W.320, V.382, S.390 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.390, A:S.390 ACT.9: 4 residues within 4Å: Chain B: Q.211, R.214, N.330, R.336 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:Q.211, B:N.330 Salt bridges: B:R.214, B:R.336 ACT.10: 5 residues within 4Å: Chain B: G.150, W.320, V.382, S.390 Ligands: HEM.12 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:W.320, B:S.390

2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.3: 18 residues within 4Å: Chain A: W.142, A.145, R.147, C.148, V.149, S.190, M.303, F.317, S.318, G.319, W.320, M.322, E.325, W.411, F.437, Y.439 Ligands: 3BT.4, GOL.7 21 PLIP interactions: 21 interactions with chain A, Hydrophobic interactions: A:W.142, A:W.142, A:W.142, A:A.145, A:R.147, A:V.149, A:F.317, A:F.317, A:F.317, A:W.320, A:E.325, A:F.437, A:F.437, A:F.437 Hydrogen bonds: A:Y.439 Water bridges: A:E.325, A:E.325, A:R.329 Salt bridges: A:R.147 pi-Stacking: A:W.142 Metal complexes: A:C.148 HEM.12: 18 residues within 4Å: Chain B: W.142, R.147, C.148, V.149, S.190, M.303, F.317, S.318, G.319, W.320, M.322, E.325, W.411, F.437, Y.439 Ligands: ACT.10, 3BT.13, GOL.16 14 PLIP interactions: 14 interactions with chain B, Hydrophobic interactions: B:W.142, B:W.142, B:R.147, B:F.317, B:F.317, B:F.317, B:W.320, B:E.325, B:F.437, B:F.437 Water bridges: B:R.329 Salt bridges: B:R.147 pi-Stacking: B:W.142 Metal complexes: B:C.148

2 x 3BT: 2-{2-[3-(2-CARBAMIMIDOYLSULFANYL-ETHYL)-PHENYL]-ETHYL}-ISOTHIOUREA(Non-covalent)

3BT.4: 12 residues within 4Å: Chain A: S.210, Q.211, P.298, V.300, N.302, F.317, G.319, W.320, Y.321, E.325, Y.439 Ligands: HEM.3 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:P.298, A:V.300, A:F.317 Hydrogen bonds: A:N.302, A:E.325, A:E.325 Water bridges: A:Y.439 3BT.13: 12 residues within 4Å: Chain B: S.210, Q.211, P.298, V.300, N.302, F.317, G.319, W.320, Y.321, E.325, Y.439 Ligands: HEM.12 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:P.298, B:V.300, B:F.317 Hydrogen bonds: B:N.302, B:N.302, B:E.325, B:E.325

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.5: 4 residues within 4Å: Chain A: R.329, H.335 Chain B: W.38 Ligands: GOL.7 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.329, A:R.329, A:H.335 EDO.14: 5 residues within 4Å: Chain A: W.38 Chain B: R.329, H.335 Ligands: GOL.8, GOL.16 5 PLIP interactions: 4 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:R.329, B:R.329, B:H.335 Water bridges: B:D.333, A:H.425

2 x CAD: CACODYLIC ACID(Non-covalent)

CAD.6: 2 residues within 4Å: Chain A: W.286, C.346 No protein-ligand interaction detected (PLIP) CAD.15: 3 residues within 4Å: Chain B: W.286, L.290, C.346 No protein-ligand interaction detected (PLIP)

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.7: 7 residues within 4Å: Chain A: R.329, A.410, W.411 Chain B: W.409, F.424 Ligands: HEM.3, EDO.5 4 PLIP interactions: 3 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:R.329, A:R.329 Water bridges: A:S.66, B:W.409 GOL.8: 9 residues within 4Å: Chain A: W.409, F.424, H.425, E.427 Chain B: S.66, V.68, W.411 Ligands: EDO.14, GOL.16 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:W.411 GOL.16: 8 residues within 4Å: Chain A: W.409, F.424 Chain B: R.329, A.410, W.411 Ligands: GOL.8, HEM.12, EDO.14 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:R.329, B:A.410, B:W.411

1 x ZN: ZINC ION(Non-covalent)

ZN.11: 4 residues within 4Å: Chain A: C.58, C.63 Chain B: C.58, C.63 4 PLIP interactions: 2 interactions with chain A, 2 interactions with chain B Metal complexes: A:C.58, A:C.63, B:C.58, B:C.63

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Raman, C.S. et al., Implications for isoform-selective inhibitor design derived from the binding mode of bulky isothioureas to the heme domain of endothelial nitric-oxide synthase. J.Biol.Chem. (2001)

Release Date

2001-07-25

Peptides

BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN

Related Entries With Identical Sequence